RecruitingNot ApplicableNCT06148285

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Recovery

Sponsor

LCMC Health

Enrollment

120 participants

Start Date

May 24, 2022

Study Type

INTERVENTIONAL

Conditions

Acute Ischemic Stroke

Summary

This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy, frequency of neurological deterioration or complications (seizure, hemorrhage, brain edema), and functional communication, activities of daily living (ADLs) and mobility.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Age 18 years and above
Ischemic stroke proven on neuroimaging
Within 7-30 days post-stroke on day 1 of treatment
Admitted to Touro Inpatient Rehab Facility

Exclusion Criteria5

Pre-stroke modified Rankin Scale Score >2
Parenchymal hemorrhagic transformation (PH1 or PH2)
Receptive aphasia such that recommendations for preventative measures to mitigate barotrauma cannot be followed
History of recurrent and unprovoked seizures requiring a change in management in the last 3 months to control seizures
Pulmonary disease requiring supplemental oxygen or daily respiratory medication management (metered dose inhalers, nebulized treatment or steroids)

Interested in this trial?

Get notified about updates and connect with the research team.